GO-CRISPR-Cas12a Biosensor Detects Sepsis Bacteria at 3,000 CFU/mL in Human Serum

Neonatal sepsis kills nearly four million infants every year, most in resource-poor settings where bacterial culture takes too long and PCR diagnostics need lab equipment that simply isn't there. The diagnostic gap — the time between when a pathogen enters the bloodstream and when clinicians can confirm what it is — is where most of those deaths happen. A 2024 study from the Juhong Chen lab at Virginia Tech and UC Riverside, published in Analytical Chemistry, demonstrates a point-of-care fluorescent biosensor that closes part of that gap. The architecture combines two technologies that have separately revolutionized molecular detection over the last decade: graphene oxide as a near-universal fluorescence quencher for short single-stranded DNA probes, and the CRISPR-Cas12a trans-cleavage mechanism for sequence-specific signal amplification. The combined “GO-CRISPR” biosensor detects Salmonella Typhimurium — one of the most common sepsis-inducing pathogens — at 3 × 10³ CFU/mL in human serum, in under an hour, without specialized lab equipment. The materials section is explicit: “Graphene oxide (GO) was purchased from Cheap Tubes Inc. (Grafton, VT).”

The Diagnostic Problem

Sepsis is what happens when the body's response to an infection cascades into systemic inflammation. Neonatal sepsis is particularly dangerous because the early signs are nonspecific — a fussy baby, a slight fever — and the time between presentation and life-threatening complications can be measured in hours. Bacterial cultures, the gold standard for identifying the causative pathogen, typically take 18-72 hours to produce a definitive result. PCR-based methods are faster but require thermal cyclers, trained molecular biology personnel, and reliable cold chains for reagents. In the resource-limited regions where neonatal sepsis is most common, neither option is practical at the point of care. The Chen lab targeted this gap: a fluorescent biosensor that can be run with a handheld plate reader, returns a result in under an hour, and detects clinically relevant bacterial concentrations directly in human serum — no nucleic acid extraction, no thermal cycling, no specialized lab.

How the GO-CRISPR Biosensor Works

The detection chemistry combines two effects to produce a sequence-specific, signal-amplified fluorescent readout:

• Step 1 — quenching: single-stranded DNA (ssDNA) probes labeled with a FAM fluorophore adsorb onto the surface of single-layer Cheap Tubes graphene oxide via π-stacking and hydrogen bonding interactions between the DNA bases and the GO sheet. GO is one of the most efficient near-universal fluorescence quenchers known — when the FAM-labeled ssDNA is adsorbed, the fluorescence is essentially extinguished. This is the “OFF” state.
• Step 2 — CRISPR-Cas12a trans-cleavage: if the target bacterial DNA (specifically, an amplicon from the highly conserved invA gene of S. Typhimurium, present in ~99% of clinically relevant Salmonella) is present, it binds the Cas12a-crRNA complex and activates the enzyme's trans-cleavage activity. Activated Cas12a indiscriminately chops any nearby ssDNA — including the FAM-labeled probes adsorbed on GO.
• Step 3 — signal recovery: the now-shortened FAM fragments detach from the GO surface (short ssDNA fragments have much weaker affinity for GO than full-length probes), and the FAM fluorescence is no longer quenched. The fluorescence signal at 520 nm under 485 nm excitation increases proportionally to target DNA concentration. This is the “ON” state — and the readout.

The elegance of the architecture is that the graphene oxide does two jobs simultaneously: it quenches the probe in the OFF state, and it acts as a passive substrate that physically holds the probe in position so the Cas12a trans-cleavage can liberate it. Conventional FRET-based fluorescent probes (paired fluorophore-quencher conjugates on the same ssDNA) require chemically modified, expensive oligonucleotides. The GO-based architecture works with cheap, unmodified single-fluorophore probes, which is critical for low-cost point-of-care economics.

Materials and Methods

Cheap Tubes single-layer graphene oxide — cited in the paper's materials section

From the paper's materials section (verbatim): “Graphene oxide (GO) was purchased from Cheap Tubes Inc. (Grafton, VT). PCR amplification was performed using a Q5 High-Fidelity PCR kit (New England Biolabs, Ipswich, MA).” The abstract confirms the specific format: “single-stranded (ssDNA) FAM probes were quenched with single-layer graphene oxide (GO).”

Single-layer GO matters here for two reasons. First, the quenching efficiency is highest for true single-layer sheets — multi-layer or thick-flake GO has reduced fluorescence quenching because of self-absorption and reduced ssDNA accessibility. Second, the single-layer format gives the highest surface-area-to-mass ratio, which means lower GO concentrations are needed for complete probe quenching — an important consideration for assay cost and for keeping the GO from interfering with the CRISPR-Cas12a enzymatic reaction.

Optimized GO-CRISPR component concentrations

The paper systematically optimized each component:

• GO concentration: 0 to 200 μM titrated against fixed probe loading; optimal at the concentration where probe quenching is complete but Cas12a activity is not inhibited.
• FAM ssDNA probe: 100 nM, 10 μL per reaction.
• Cas12a + crRNA: optimized concentrations of 120 nM each, paired against fixed Salmonella target DNA.
• Target gene: the highly conserved invA gene, present in ~99% of clinically relevant Salmonella strains — a deliberate choice to keep the assay specific to Salmonella but broad enough to catch most clinical isolates.
• Readout: fluorescence intensity at 520 nm emission, 485 nm excitation, measured at 30 minutes at 37°C or room temperature.

Specificity testing

The biosensor was challenged with several competing organisms to verify specificity: E. coli K12 (ATCC 25404), Bacillus subtilis (ATCC 23857), and Listeria monocytogenes. The crRNA was designed to be sequence-specific to the Salmonella invA gene; the trans-cleavage was activated only by Salmonella target DNA, and the competing organisms produced no false-positive fluorescence above background.

Human serum matrix testing

Sepsis-inducing bacteria circulate in the bloodstream. The paper tested the GO-CRISPR system in human serum spiked with Salmonella at concentrations from 10¹ to 10⁷ CFU/mL. Serum is a complex matrix (proteins, lipids, salts, nucleases) that breaks many fluorescent biosensors. The GO-CRISPR system maintained its sensitivity and specificity in serum — the practical sensitivity limit was 3 × 10³ CFU/mL.

Key Results

Detection sensitivity — the headline number

The GO-CRISPR system detected S. Typhimurium in human serum down to 3 × 10³ CFU/mL. For context, clinical neonatal sepsis is typically associated with bacteremia in the range of 10¹-10⁴ CFU/mL of blood. The paper's sensitivity puts it at the upper end of clinically relevant sensitivity for direct serum detection without enrichment culture — meaningful for screening applications and for confirming clinical suspicion of bacteremia in symptomatic neonates.

Speed — under one hour, no thermal cycling

Total assay time was under one hour from sample preparation to readout. The PCR amplification step uses a single isothermal incubation (no thermal cycler needed for the Cas12a-based version of the assay), and the fluorescence readout is taken at the 30-minute mark. By comparison, blood culture takes 18-72 hours; multiplex PCR panels take 1-6 hours but require thermal cycling. Under-one-hour, room-temperature readout puts the GO-CRISPR architecture in the operational envelope of a clinic, an emergency department, or a field hospital — not just a centralized lab.

Specificity — no false positives from common bystanders

The crRNA was designed against the conserved invA gene of Salmonella, which is present in ~99% of clinically relevant Salmonella isolates but absent from E. coli, B. subtilis, and L. monocytogenes. Challenge experiments confirmed that the biosensor produced no false-positive fluorescence from these competing organisms — the trans-cleavage activity of Cas12a is sequence-gated by the crRNA, and the GO-quenched probe stays dark unless the correct target DNA is present.

Why Cheap Tubes Single-Layer GO Works for This Biosensor

• True single-layer format — the quenching efficiency is highest for monolayer GO sheets, because reduced sheet thickness eliminates the self-absorption and inner-filter effects that reduce quenching efficiency in multi-layer or thick-flake GO.
• High surface-area-to-mass ratio — single-layer GO provides the highest ssDNA-adsorbing surface area per milligram. Lower GO concentrations achieve complete probe quenching, which both reduces assay cost and avoids interference with the Cas12a enzymatic reaction at higher GO loadings.
• Consistent surface chemistry — the π-stacking and hydrogen bonding interactions that adsorb ssDNA to GO depend on a reproducible oxygen functional group distribution. Inconsistent or partially-reduced GO would produce variable quenching baseline, which would propagate as noise in the limit of detection.
• Aqueous-dispersible — the biosensor runs in aqueous buffer at near-neutral pH (compatible with both DNA adsorption and Cas12a activity). Single-layer GO disperses cleanly in this environment without surfactants that would interfere with the enzymatic reaction.

Application Areas

• Point-of-care infectious disease diagnostics — the direct target: rapid identification of sepsis-inducing bacteria in clinical settings where blood culture and PCR labs are not available.
• Multiplex CRISPR biosensor arrays — the paper explicitly notes that the architecture extends to multiple crRNAs in the same system, enabling simultaneous detection of E. coli, S. aureus, and other common sepsis pathogens.
• Food and water pathogen testing — Salmonella, Listeria, and pathogenic E. coli detection in food matrices for outbreak surveillance and quality assurance, using the same GO-CRISPR architecture.
• Antibiotic resistance gene detection — the Cas12a trans-cleavage mechanism is sequence-agnostic to what triggers it; the crRNA can be designed to detect carbapenemase, MRSA mecA, or other resistance markers directly from clinical samples.
• Veterinary diagnostics — livestock sepsis pathogens (zoonotic Salmonella, E. coli, Mycoplasma) can be detected from animal serum with the same architecture and crRNA redesign.
• Nucleic acid quenching probes for FRET biosensors — the same GO + ssDNA quenching mechanism is used in scores of aptamer- and DNAzyme-based biosensors beyond CRISPR — including detection of heavy metals, mycotoxins, and small-molecule analytes.

Order the Cheap Tubes GO Used in This Study

The single-layer graphene oxide used in the Chen lab's GO-CRISPR biosensor is available directly from Cheap Tubes. Order the matching SKU: Single Layer Graphene Oxide. Other GO formats (reduced GO, GO powder, GO gel, larger and smaller lateral grades) are available in the Graphene Oxide product category. Research and production volumes, SDS / TDS / CoA included, custom dispersion concentrations on request.

Frequently Asked Questions

Citation